Bioelectronic-medicine startup developing neuromodulation for autoimmune diseases
| Date | Round | Amount |
|---|---|---|
| Nov 2022 | Series A California bioelectronic-medicine startup Boomerang Medical closed a $15M Series A led by Arboretum Ventures and Hatteras Venture Partners to advance IBD neuromodulation trials. | $15M |